Novo Nordisk pauses ad campaign for obesity drug Wegovy amid unprecedented demand
Novo Nordisk is hitting the brakes on a national advertising campaign for obesity drug Wegovy.
After launching a TV commercial regionally earlier this year, Novo …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.